Associate Professor, Internal Medicine, Mayo Medical School

Rheumatology

Dr. Tim Bongartz, MD

Doctor Tim Bongartz, MD is an expert in the field of Rheumatology. He has 2 awards "Fellow (FACR)" and "Fellow". Bongartz has written publications. He has 39 publications published with PubMed. The lastest publication is: 'Estrogen, SNP-Dependent Chemokine Expression and Selective Estrogen Receptor Modulator Regulation.' Dr. Tim Bongartz accepts Medicare.

Publications

Estrogen, SNP-Dependent Chemokine Expression and Selective Estrogen Receptor Modulator Regulation.
Dual-energy CT for the diagnosis of gout: an accuracy and diagnostic yield study.
Incidence and mortality of obstructive lung disease in rheumatoid arthritis: A population-based study.
Immunology: Zoster vaccine and biologic agents: time to question a paradigm?
Incidence of Spondyloarthropathy in Patients with Crohn's Disease: A Population-based Study.
Etanercept therapy in rheumatoid arthritis and the risk of malignancies: a systematic review and individual patient data meta-analysis of randomised controlled trials.
Treatment of active psoriatic arthritis with the PPARgamma ligand pioglitazone: an open-label pilot study.
[Overview of the program of the 6th Workshop of the Professional Society of Regional Cooperative Rheumatism Centers].
Predictive and potentially predictive factors in early arthritis: a multidisciplinary approach.
Successful treatment of psoriatic onycho-pachydermo periostitis (POPP) with adalimumab.
Morphological and quantitative assessment of mast cells in rheumatoid arthritis associated non-specific interstitial pneumonia and usual interstitial pneumonia.
Citrullination in extra-articular manifestations of rheumatoid arthritis.
[Detection of psoriasis arthritis with the GEPARD patient questionnaire in a dermatologic outpatient setting].
Perioperative care for patients with rheumatic diseases.
Identification of intraarticular and periarticular uric acid crystals with dual-energy CT: initial evaluation.
Can treatment of chronic inflammatory diseases reduce the risk of diabetes mellitus?
Histoplasmosis infection in patients with rheumatoid arthritis, 1998-2009.
An unusual soft tissue tumor.
Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study.
Therapy: The risk of herpes zoster: another cost of anti-TNF therapy?
Incidence and risk factors of prosthetic joint infection after total hip or knee replacement in patients with rheumatoid arthritis.
Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in r...
Morphologic and quantitative assessment of CD20+ B cell infiltrates in rheumatoid arthritis-associated nonspecific interstitial pneumonia and usual interstitial pneumo...
Large-vessel involvement in giant cell arteritis.
Tumor necrosis factor antagonists and infections: the small print on the price tag.
Interstitial lung disease in connective tissue diseases: what are the important questions?
Association of Crohn''s disease and latent celiac disease: a case report and review of the literature.
Tumor necrosis factor alpha drives cadherin 11 expression in rheumatoid inflammation.
Malignancy and biologic therapy in rheumatoid arthritis.
Tocilizumab for rheumatoid and juvenile idiopathic arthritis.
Elective orthopedic surgery and perioperative DMARD management: many questions, fewer answers, and some opinions...
Tumor necrosis factor antagonists and cancer in patients with rheumatoid arthritis.
CD56-expressing T cells that have features of senescence are expanded in rheumatoid arthritis.
Investigation, explanation, and apology for incomplete and erroneous disclosures.
Citrullinated proteins in rheumatoid arthritis: crucial...but not sufficient!
Response to commentary by Dixon and Silman on the systematic review and meta-analysis by Bongartz et al.
Is tacrolimus effective for treating antisynthetase-associated interstitial lung disease?
Impact of thiopurine methyltransferase activity and 6-thioguanine nucleotide concentrations in patients with chronic inflammatory diseases.

Doctors Specialties

Internal Medicine
Rheumatology

Accepted Insurances

Choice Plus POS II
Blue Card PPO
Blue Cross Blue Shield of Illinois PPO
Blue Cross Accord
Cigna PPO
Great West Healthcare-Cigna PPO
Open Access Plus
Choice Care PPO
MultiPlan PPO
PHCS Network PPO
Choice Plus POS
Options PPO

Awards

Fellow (FACR)
Fellow

Education

Mayo School of Graduate Medical Education
Ludwig Maximilian University of Munich Faculty of Medicine

Hospital

Mayo Clinic - Rochester, Minnesota

Drug Facts

NPI NUMBER		1356461024
NPPES Provider LastName		BONGARTZ
NPPES Provider FirstName		TIM
NPPES Provider ZIPCode		559050001
NPPES Provider State		MN
Specialty Description		Rheumatology
Total Claim Count		370.0
Distinct Opioid Count		1.0
Opioid Claim Count		11.0
Percent Opioid Claims		2.97

Helpful Reviews

Give Anonymous Review

Medicare Facts

National Provider Identifier [NPI]	1356461024
Last Name Of The Provider	BONGARTZ
First Name Of The Provider	TIM
View All

Similar Doctors

	Dr. Jorge A. Brenes Salazar, MD This Doctor is OpenDoctor Recommended.
	Dr. Kenley D. Schmidt, MD This Doctor is OpenDoctor Recommended.
	Dr. Jason H. Szostek, MD This Doctor is OpenDoctor Recommended.
	Dr. Kevin R. Brough, MD
	Dr. Steven R. Ytterberg, MD This Doctor is OpenDoctor Recommended.
	Dr. Vaidehi R. Chowdhary, MD This Doctor is OpenDoctor Recommended.
	Dr. Thomas G. Osborn, MD This Doctor is OpenDoctor Recommended.
	Dr. Sudumpai Jarukitsopa, MD
	Dr. Harvinder S. Luthra, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. George L. Allen, MD
	Dr. Krati Chauhan, MD This Doctor is OpenDoctor Recommended.
	Dr. Sneha R. Kaggal, MD This Doctor is OpenDoctor Recommended.
	Dr. John M. Davis III, MD This Doctor is OpenDoctor Recommended.
	Dr. Courtney A. Shourt, MD This Doctor is OpenDoctor Recommended.
	Dr. Timothy B. Niewold, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Thomas B. Tomasi Jr., MD